Member Info for L2analyst

Heading straight for 10p

Government all over the world are pouring billions of pounds trying to find vaccine and we are the 1st to come up with solutions

Likes of gsk will not stand aside , all the major pharmaceutical companies will want this challenge model to develop the vaccine, more news to come

Flu vac also comes into play now

Expecting double digits today

Relentless buying, this is oversold

He just confirmed they are working with the government as well

Progress regarding strategic discussions related to the assets (FLU-v and AGS-v) in our joint venture Imutex,
and, in particular, around the continued development of the FLU-v vaccine, has been slower than we would
have liked. Business development discussions with interested parties are still ongoing and we are continuing
to explore a number of options to enable continued development of the FLU-v vaccine. We are in the process
of setting up meetings with key regulatory authorities (FDA and EMEA) to discuss the status of and
development pathway for FLU-v and anticipate these meetings will take place in Q42019. These meetings are
expected to deliver answers to some of the questions raised by potential interested parties and management
believes this could lead to further positive traction in those strategic discussions.

Back to blue, mm screwed some up

Moniman hvivo got parties already interested in the flu vaccine, see in their results, things are being speeded up now

Bid price rising so seller drying up fast now

Someone is taking them shares, selling should dry up

Surely they got to be done, just look at all the trades for the last few weeks

You got to lol regarding the share price

It added that these services are “particularly relevant and topical” in the current climate, given the spread of the coronavirus.

London-based hVIVO has Europe's only commercial 24-bed quarantine clinic and on-site virology laboratory and is the only company globally with the capability to run an RSV human challenge study.

With sea of blues this should burst pretty soon

Here comes the buys, shake is over

Current price is a joke

Comek great post, im here for that vaccine development, trevor Phillips said they will out license the product for stage 3, just look at imm deal, this is worth 100s of millions

U.S. House passes $8.3 billion bill to battle coronavirus; Senate vote due Thursday

David Morgan, Richard Cowan

WASHINGTON (Reuters) - The U.S. House of Representatives overwhelmingly approved on Wednesday an $8.3 billion bill to combat the spread of the new coronavirus and develop vaccines for the highly contagious disease, sending it to the Senate for final passage.

FILE PHOTO: U.S. President Donald Trump is flanked by Health and Human Services (HHS) Secretary Alex Azar and National Institutes of Health Doctor Kizzmekia Corbett, research fellow at the NIH Vaccine Research Center, as he listens to Director of National Institute of Allergy and Infectious Diseases Anthony Fauci following a briefing at the Vaccine Research Center in Bethesda, Maryland, U.S., March 3, 2020. REUTERS/Leah Millis

Reflecting the urgency among lawmakers to address the growing coronavirus crisis, the House voted 415-2 on the bill just hours after negotiators unveiled its contents.

A Senate vote was scheduled for Thursday.

It includes money to expand testing for the virus, which has infected at least 129 people in the United States. Two more deaths were reported on Wednesday, taking the U.S. toll to 11.

With the White House backing the effort, congressional leaders worked to win fast passage so that President Donald Trump could potentially sign it into law this week.

“We must quickly enact this legislation. Lives are at stake,” House Appropriations Committee Chairwoman Nita Lowey, a Democrat, said in a statement.

The measure would provide far more money than the $2.5 billion initially sought by the Trump administration.

Shortly before the vote, the top four Democratic and Republican leaders in Congress received a classified briefing about contingency plans for Congress if there was a coronavirus outbreak in Washington.

An estimated 3 million people come through the Capitol Visitor Center each year.

Following the meeting, the lawmakers brushed off reporters’ questions on whether plans were needed for Congress to meet somewhere else or whether public access to the Capitol might eventually be curtailed.